Rh5 is a leading malaria vaccine candidate and plays an essential role, in complex with CyRPA and Ripr (Volz et al., 2016, Wong et al., 2019) and in binding to the erythrocyte surface protein basigin (Crosnier et al., 2011). This evidence concerns the gene BSG and malaria.